Browse studies

Find your next paid study

27,270 recruiting studies available now

A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination With the Modified Gemcitabine and Nab-Paclitaxel Regimen Versus the Standard Gemcitabine and Nab-Paclitaxel Regimen for the Treatment of Patients With Metastatic Pancreatic Ductal Pancreatic Adenocarcinoma Cancer (MAPKeeper 301)

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Immuneering CorporationNCT07562152

Functional, Clinical, and Performance Outcomes Following Pelvic and Acetabular Fracture: A Prospective Observational Study

The purpose of this study is to understand the trajectory of function and self-reported outcomes of patients following pelvic and acetabular, treated both oper…

Pelvic FractureAcetabular FracturePubic Rami Fracture

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT04615104

Phase 1

A Phase I, Randomized, Placebo-controlled, Double-blind, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection for Subcutaneous Use in Adult Participants With Obesity or Are Overweight

This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerabi…

Chronic Weight Management

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ascletis Pharma (China) Co., LimitedNCT07893093

Neurovascular Product Surveillance Registry (NV PSR INSPIRE) Pipeline™ Vantage Embolization Device With Shield Technology™ Post Approval Study (PAS)

The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and e…

Intracranial Aneurysm

Estimated

~$10 – $750

Actual pay is set by the research site.

Medtronic Neurovascular Clinical AffairsNCT06604884

Phase 3

A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can tre…

Diabetic RetinopathyMacular Edema

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07705607

Phase 1

An Open-Label, Multicenter, Phase Ib Dose Randomization Study of Bulumtatug Furvedotin (BFv; 9MW2821) in Subjects With Recurrent or Metastatic Triple-Negative Breast Cancer Previously Treated With Antibody-Drug Conjugates

The goal of this clinical trial is to investigate if treatment with bulumtatug fuvedotin is effective in triple-negative breast cancer patients who have previo…

Triple Negative Breast Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Mabwell (Shanghai) Bioscience Co., Ltd.NCT06908928

Phase 3

A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

The goal of this study is to compare how well sonrotoclax plus obinutuzumab works versus venetoclax plus rituximab in treating adults with relapsed and/or refr…

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

BeOne MedicinesNCT06943872

Phase 1

A Phase I Study of Human Amnion Membrane Powder for Enhanced Wound Healing of Mohs Surgery Wound Sites

The purpose of this research study is to test the safety of the amnion membrane powder to see if it improves wound healing in patients undergoing Mohs surgery …

Wound Heal

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT07680023

Phase 3

Prospective, Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating a 4% Lidocaine Patch for Pain During Epidural Placement in Laboring Women

Needle phobia can negatively affect the patient experience and may contribute to anxiety during labor procedures. During epidural placement, a standard intrade…

Needle Phobia

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Ohio State UniversityNCT07700108

Phase 1

A Phase 1b Single Ascending Dose Study to Evaluate the Safety of VERVE-201 in Patients With Refractory Hyperlipidemia

VT-20101 is an Open-label, Phase 1b, Single-ascending dose study that will evaluate the safety of VERVE-201 administered to patients with Refractory Hyperlipid…

HypercholesterolemiaHypertriglyceridemiaRefractory Hyperlipidemia

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Verve Therapeutics, Inc.NCT06451770

Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support

This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane…

Drug Effect

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT03593408

Evaluation of Patients With Gastrointestinal Disease

Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers wa…

Lower GI DiseaseGastrointestinal Diseases

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05041374